|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.64 USD | -0.97% |
|
+2.25% | -0.52% |
| 05-17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
| 05-17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
May 8 (Reuters) - Pfizer Inc has agreed to settle more than 10,000 cases about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal. (Reporting by Leroy Leo in Bengaluru; Editing by Devika Syamnath)
| 1st Jan change | Capi. | |
|---|---|---|
| -0.52% | 162B | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
PFIZER, INC. 
